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Abstract
Background: Despite the positive impact of Palliative Care (PC) on the quality of life for patients and their relatives,
the implementation of PC in non-cancer health-care delivery in the EU seems scarcely addressed. The aim of this
study is to assess guidelines/pathways for integrated PC in patients with advanced Chronic Heart Failure (CHF) and
Chronic Obstructive Pulmonary Disease (COPD) in Europe via a systematic literature review.
Methods: Search results were screened by two reviewers. Eligible studies of adult patients with CHF or COPD published
between 01/01/1995 and 31/12/2013 in Europe in 6 languages were included. Nine electronic databases were searched, 6
journals were hand-searched and citation tracking was also performed. For the analysis, a narrative synthesis was employed.
Results: The search strategy revealed 26,256 studies without duplicates. From these, 19 studies were included in the review;
17 guidelines and 2 pathways. 18 out of 19 focused on suffering reduction interventions, 13/19 on a holistic approach and
15/19 on discussions of illness prognosis and limitations. The involvement of a PC team was mentioned in 13/19 studies, the
assessment of the patients’ goals of care in 12/19 and the advance care planning in 11/19. Only 4/19 studies elaborated on
aspects such as grief and bereavement care, 7/19 on treatment in the last hours of life and 8/19 on the continuation of goal
adjustment.
Conclusion: The results illustrate that there is a growing awareness for the importance of integrated PC in patients with
advanced CHF or COPD. At the same time, however, they signal the need for the development of standardized strategies so
that existing barriers are alleviated.
Background
The World Health Organization’s (WHO) “Global Bur-
den of Disease” study estimates that, since 2002, chronic
or non-communicable conditions have accounted for
87 % of deaths in high-income countries. Moreover, the
proportion of deaths worldwide due to such conditions
is projected to reach 69 % by 2030 [1].
Chronic heart failure (CHF) and Chronic Obstructive
Pulmonary Disease (COPD) are two prominent causes
of chronic conditions. CHF in particular is the leading
cause of death worldwide whereas COPD is projected to
rise to the third highest cause by 2030 [2, 3]. In Europe,
more specifically, CHF and COPD are responsible for
1.9 and 2.9,000,000 annual deaths, respectively [4, 5].
Palliative Care (PC) is a specialized medical care tar-
geted in patients living with life-threatening conditions.
The aim of PC is the promotion of physical and
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psychosocial health and thus the improvement of the
quality of life of such patients and their families. In order
for these objectives to be reached, the focus of PC is typ-
ically placed on three principal areas: 1) the alleviation
or control of symptoms and side effects of either the dis-
ease and/or curative treatment, 2) the timely and con-
tinuously updated communication of treatment goals
between physicians, patients and their families and 3)
the efficient psychological, social and spiritual support
for both patients and their families throughout the
course of the illness trajectory [6].
Owing to its generic definition, PC can in principle be
integrated with curative treatment for both malignant
and non-malignant disease [6]. Consequently, even
though PC mostly began in cancer care in Europe, it is
not surprising that awareness for patients with non-
malignant disease has increased [7, 8]. Moreover, extant
studies have empirically showed that PC practices can
significantly improve the quality of life of patients with
chronic conditions [9]. Importantly, there is a general
acknowledgement that optimal care for patients with ad-
vanced stages of CHF and COPD should rest upon an
integrated and holistic approach while simultaneously
taking into account patients and family needs through-
out the course of the illness [8, 10].
Delivery of PC in patients with advanced CHF and
COPD, however, is quite challenging because of the fol-
lowing three barriers i) both diseases are associated with
complicated trajectories resulting in uncertain prognosti-
cation [11, 12], ii) sudden deaths are common making
planning difficult [13, 14], iii) since there is usually a var-
iety of treatment options, patients are not typically well
informed about their disease and therefore do not par-
ticipate actively in decision making. Further, this inhibits
the discussion of end-of-life issues [15, 16]. With current
evidence showing that access to PC is dominated by pa-
tients with cancer [17-19], it is conceivable that these
barriers have a prominent role on this aspect.
The implementation of PC in both malignant and
non-malignant disease is often based on guidelines and/
or pathways. G uidelines are defined as systematically
developed statements to assist practitioners and patient
decisions about appropriate health care for specific clin-
ical circumstances. Care pathways, on the other hand,
are defined as complex interventions for the mutual de-
cision making and organisation of care processes for a
well-defined group of patients during a specified period.
Consequently, existing guidelines and pathways contain
valuable information on current practices for PC in pa-
tients with non-malignant disease. Additionally, they
provide concise answers to two questions that are crit-
ical in planning PC for patients with non-malignant dis-
ease: a) when should PC initiate and b) how to integrate
PC with curative treatment.
The aim of this study is to systematically review guide-
lines and pathways of integrated PC for people with ad-
vanced CHF and COPD in Europe. By doing so, we
obtain an overview of the current level of integration of
PC in advanced CHF and COPD in Europe while we
document and critically evaluate current practices and
recommendations. This study is part of the multi-
country European project InSup-C that focuses on inte-
gration of PC in cancer and chronic disease in Europe
(http://www.insup-c.eu/).
Methods
To date, a unanimously agreed definition of integrated
PC does not exist. For the needs of this study the follow-
ing definition based on consensus of the InSup-C ex-
perts has been employed:
“Integrated palliative care involves bringing together
administrative, organisational, clinical and service
aspects in order to realise continuity of care between
all actors involved in the care network of patients
receiving palliative care. It aims to achieve quality of
life and a well-supported dying process for the patient
and the family in collaboration with all the care givers
(paid and unpaid)”.
Search strategy
The search strategy for this review included an elec-
tronic search of the following databases: PubMed, Web
of Science, The Cochrane Central Register of Controlled
Trials (CENTRAL), CINAHL, EMBASE, BNI, AMED,
Table 1 Inclusion Criteria describes the inclusion criteria for the
guidelines and pathways of this study
1. Guidelines and pathways for adult patients
2. Guidelines and pathways for CHF and COPD (latest possible versions)
3. European guidelines and pathways.
4. Guidelines and pathways published from 01-01-1995 to 31-12-2013
(with the start date based on the publication of the Calman-Hine
report [81])
5. Languages: English, French, German, Dutch, Hungarian and Spanish
(the languages of the authors)
6. Guidelines and pathways that fulfilled at least 2 out of 11 IPC criteria
(see explanation below and Table 3).
Table 2 Exclusion criteria describes the exclusion criteria for the
guidelines and pathways of this study
1. Papers on chronic disease in general.
2. End-of-life guidelines and pathways.
3. General palliative care guidelines/pathways.
4. Guidelines and pathways for children.
5. Guidelines/pathways in languages other than the included ones.
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NHS Evidence, and National Guidelines Clearinghouse.
The exact search terms and keywords used for the elec-
tronic search are available as an electronic supplement
to this paper as well as in the InSup-C website
www.insup-c.eu. Besides the electronic database search,
the search strategy included citation reference and the
hand-searching of the following journals: European Jour-
nal of Palliative Care, BMJ Supportive & Palliative care,
Palliative Medicine, Journal of Pain and Symptom Man-
agement, Medicina Paliativa.
Additionally, for the grey literature search we followed
two strategies: i) we contacted named individuals within
national scientific medical organizations in order to
gather information on guidelines and pathways for CHF
and COPD and ii) we performed an electronic search in
Google (which was translated in the other six languages
of the authors participating in this study). In the UK due
to the size of the grey literature, we performed an elec-
tronic search in the NHS Evidence database.
Selection criteria
A systematic review of the literature was conducted of
guidelines and pathways about integrating PC into
standard care for patients with advanced CHF and
COPD. In conformance with the objectives of the
InSup-C, the present review is confined to the identifica-
tion of existing guidelines and pathways in Europe. The
other selection criteria of the study are presented in the
Table 1 and the exclusion criteria in Table 2 below:
The sixth inclusion criterion concerned the complete-
ness of the content of the included guidelines/ pathways
with regard to integrated palliative care. In order to
measure the level of the integration of the PC content of
the studies we employed a widely used tool with 11 cri-
teria based on the study by Emanuel et al. 2004 [20]
(Table 3). A consensus in the InSup-C consortium was
reached for the determination of the entry level filter
(fulfilment of at least two out of 11 criteria) of this tool.
Selection procedure
Two authors (NS and KVB) screened all the English
search results based on their title and their abstract. The
guidelines and pathways that were in the other included
languages were screened and translated by two native
speaker researchers. Subsequently, NS and KVB sourced
and reviewed the translated full texts based on the inclu-
sion criteria and exclusion criteria. Disagreements were
reconciled by either consensus or by open discussions in
the InSup-C project meetings.
Data extraction
An extraction form based on the study by Hawker et. al
(2002), and it was modified towards the project goals
was used to examine included papers [21]. The first two
authors extracted data from English guidelines/pathways
independently and then cross-checked the results. The
same procedure was followed by two native speaker re-
searchers for the non-English ones. Discrepancies were
resolved by consensus.
Data synthesis
Due to heterogeneity of the results, a narrative synthesis
was deemed more appropriate and guidelines are pre-
sented in Table 4 and pathways in Table 5, while an
overall synthesis is presented in Table 6.
Quality assessment
For the evaluation of the quality of the evidence a four-
point Likert scale tool (high quality (4) to very low qual-
ity (1)) was developed by the project consortium
(Table 4). It is important to highlight that the assessment
employed in the present systematic review does not as-
sess the quality of the implementation of the included
Table 4 Quality assessment of the Evidence describes the four different categories of the quality assessment of the included
guidelines and pathways of this study
High Quality Evidence Medium Quality Evidence Low Quality Evidence Very Low Quality Evidence
Guidelines/pathways based on both
systematic reviews and consensus methods
or those developed following the NICE
protocol [82].
Guidelines/pathways based
on systematic review only
or based on other types of
well referenced evidence.
Guidelines/pathways
based on consensus
methods only.
Guidelines/pathways that are
unclear (e.g. apparently evidence
based but failing to clarify how this
was obtained).
Table 3 Integrated Palliative Care (IPC) Criteria describes the
eleven criteria of Integrated Palliative Care for the evaluation of
the content of the included guidelines and pathways
1. Discussion of illness limitations and prognosis.
2. Recommendations for conducting a whole patient assessment
including the patient’s physical, social, psychological, and spiritual
issues, their family and community setting.
3. Recommendations for when to make these assessments
4. Recommendations on when PC should be integrated-referral criteria.
5. Assessment of the patient’s goals for care.
6. Continuous goal adjustment as the illness and the person’s
disease progresses.
7. Palliative care interventions to reduce suffering as needed.
8. Advance care planning.
9. Recommendation of involving a PC team.
10. Recommendations on care during the last hours of living.
11. Recommendations on grief and bereavement care.
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Table 5 Characteristics of included guidelines
Title/Country/Year Disease Setting Integrated Palliative Care Criteria (IPC) Quality of
Evidence
Multidisciplinary guideline Heart Failure/
The Netherlands/2010 [22].
Heart
Failure
inpatient/
outpatient
9 IPC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, Continuous goal adjustment, Suffering reduction,
ACP*, Involvement of PC team, Last hours of living care.
High
Guideline Palliative care for people with
COPD/The Netherlands/ 2011 [23].
COPD inpatient/
outpatient
8 IPC : Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments, Timing
of PC introduction, Patient’s goals, Suffering reduction, ACP,
Involvement of PC team.
Medium
Guideline COPD/ The Netherlands/ 2010 [24]. COPD inpatient/
outpatient
5 IPC: Discussion of illness limitations and prognosis,
Timing of PC introduction, Patient’s goals, Continuous
goal adjustment, Suffering reduction.
Low
Guideline Heart failure/The Netherlands/2010 [25]. Heart
failure
inpatient/
outpatient
7 IPC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, Suffering reduction, Involvement of PC team, Last
hours of living care.
Low
Multidisciplinary guideline diagnostics and treatment
of COPD/ The Netherlands/ 2010 [26].
COPD inpatient/
outpatient
5 IPC : Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, Suffering reduction.
High
95 Management of chronic heart failure. A national
clinical guideline/UK- Scotland/2007 [27].
Heart
failure
inpatient/
outpatient
4 IPC: Discussion of illness limitations and prognosis,
Timing of holistic assessments, Patient’s goals, Suffering
reduction.
High
Living and dying with advanced heart failure: a
palliative care approach/UK- Scotland/2008 [28].
Heart
Failure
inpatient/
outpatient
10 IPC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Patient’s goals, Continuous
goal adjustment, Suffering reduction, ACP, Involvement
of PC team, Last hours of living care.
High
NICE clinical guideline 101: Management of
chronic obstructive pulmonary disease in adults
in primary and secondary care/UK/2010 [29].
COPD inpatient/
outpatient
3 IPC: Holistic assessments, Suffering reduction,
Involvement of PC team.
High
Chronic Obstructive Pulmonary Disease Services/
UK- Scotland/ 2010 [30].
COPD inpatient/
outpatient
5 IPC: Discussion of illness limitations and prognosis,
Holistic assessments, , Patient’s goals, ACP, Involvement
of PC team.
High
Global Strategy for Diagnosis, Management, and
Prevention of COPD/UK/ 2013 [31].
COPD inpatient/
outpatient
7 IPC: Discussion of illness limitations and prognosis,
Timing of holistic assessments, Timing of PC introduction,
Continuous goal adjustment, Suffering reduction, ACP,
Involvement of PC team.
High
Heart Disease: quick reference guide/UK/ 2012 [32]. Heart
Failure
inpatient/
outpatient
3 IPC: Discussion of illness limitations and prognosis,
Timing of PC introduction, Suffering reduction.
Low
IMPRESS guide for commissioners on supportive and
end of life care for people with COPD/UK/ 2012 [33].
COPD inpatient/
outpatient
9 IPC : Discussion of illness limitations and prognosis,
Holistic assessments, Timing of PC introduction, Patient’s
goals, Continuous goal adjustment, Suffering reduction,
ACP, Involvement of PC team, Grief and bereavement care.
High
Services for people with chronic obstructive pulmonary
disease CMG43/UK/ 2011 [34].
COPD inpatient/
outpatient
11 IPC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Patient’s goals, Continuous
goal adjustment, Suffering reduction, ACP, Involvement
of PC team, Last hours of living care, Grief and
bereavement care.
High
Services for people with chronic heart
failure/UK/2011 [35].
Heart
Failure
inpatient/
outpatient
9 IPC : Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments, Timing
of PC introduction, Suffering reduction, ACP, Involvement
of PC team, Last hours of living care, Grief and bereavement
care.
High
Chronic obstructive pulmonary disease: Management
of chronic obstructive pulmonary disease in adults
in primary and secondary care/UK/ 2010 [36].
COPD inpatient/
outpatient
2 IPC: Suffering reduction, Involvement of PC team. High
Best practice guidance on developing a respiratory
service specification/UK/ 2008 [37].
COPD inpatient/
outpatient
2 IPC:, Suffering reduction, Last hours of living care. Low
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guidelines/pathways. Rather, it provides a means of
evaluating the principles upon which they have been
proposed.
Results
We identified a total of 31,298 potentially relevant arti-
cles, with 28,277 originating from the electronic data-
base searching and 3021 from the grey literature and the
citation tracking. The process of contacting professional
experts did not return any further result. After the ex-
clusion of the duplicate results we had 26,256 results of
which 25,223 were excluded based on their titles or ab-
stracts. From the 1033 remaining results, we identified
235 guidelines/pathways eligible for full-text screening.
The final review included 17 guidelines and two path-
ways (in total 19) [22–40]. The properties of these stud-
ies are available in Tables 5 and 6. A flow diagram of the
selection procedure and results (using the PRISMA tool
[41]) is presented in Fig. 1 below.
Seventeen guidelines and two pathways were included
in the study. Of the 17 guidelines included in the final
review, eleven originated from UK, five from the
Netherlands and one from more than one European
country. Of the two pathways, one pathway originated
from Spain and one from UK. From these results, eleven
guidelines/pathways were concerned with COPD and
eight with CHF. A synthesis of the key point recommen-
dations for all the included CHF and COPD guidelines
and pathways in relation to the 11 IPC Criteria is pre-
sented in Table 7. Moreover, throughout this section re-
sults correspond to the combined set of pathways and
guidelines.
There was almost unanimous agreement (18/19) that
the focus of PC interventions should be placed on re-
duction of suffering through the provision of appropriate
medication and psychological support. Recommenda-
tions for discussions about illness prognosis and limita-
tions were found in 15 out of 19 of the included
guidelines and pathways.
It was found that the holistic approach, i.e. the assess-
ment of the patient’s physical, psychological, social and
spiritual issues, was recommended in 13 out of 19 guide-
lines/pathways, however, only 8/19 included instructions
on when these assessments should take place.
Recommendations concerning the involvement of a
PC team were reported in 13/19. All these 13 guidelines
and pathways additionally promote the composition of a
multidisciplinary PC team that involves professionals
from different disciplines e.g. physicians, disease special-
ists, nurses, psychologists, psychiatrists, chaplains, nutri-
tionists, physiotherapists, etc. Seven guidelines/pathways
recommend the involvement of personnel that are add-
itionally trained in PC. On the other hand, the utilization
of advance care planning and the assessment of the pa-
tients’ goals of care were mentioned in 11/19 and 12/19
guidelines and pathways respectively.
From the included guidelines/pathways 12 out of 19
discussed explicitly the referral criteria, i.e. the point at
which PC should be initiated. However, among those
that made an explicit recommendation, the analysis
yielded large variations. A minority (4/19) used the spe-
cific referral criteria mentioned in the Gold Standards
Framework or stages III or IV in the New York Heart
Association (NYHA) [42] or stages III and IV in the
Global Initiative for Chronic Obstructive Lung Disease
(GOLD) [22, 24, 28, 35, 43]. The timing as to when to
initiate PC varied with 3/19 saying in the last six months
but none of them invoked the surprise question [23, 25,
26]. One guideline reported that PC should be applied in
the last 12 months of life [39], whereas another one
Table 5 Characteristics of included guidelines (Continued)
ESC Guidelines for the diagnosis and treatment of
acute and chronic heart failure 2012/Europe/2012 [38].
Heart
Failure
Acute
setting
8 IPC: Discussion of illness limitations and prognosis, Holistic
assessments, Timing of holistic assessments, Timing of PC
introduction, Continuous goal adjustment, Suffering
reduction, ACP, Involvement of PC team.
High
The included guidelines are described in different categories: title, country and year, type of disease, setting, Integrated Palliative Care (ICP) criteria and quality of
evidence. ACP= Advance Care Planning, COPD= Chronic Obstructive Pulmonary Disorder.
Table 6 Characteristics of included pathways
Title/Country/Year Disease Setting Integrated Palliative Care Criteria (IPC) Quality of
Evidence
Consensus on Integrated Care for Disease
Exacerbations of COPD. (ATINA-EPOC)/Spain/2012 [39].
COPD - 8 IPC: Discussion of illness limitations and prognosis,
Holistic assessments, Timing of holistic assessments,
Timing of PC introduction, Patient’s goals, Continuous
goal adjustment, Suffering reduction, ACP*.
Low
End of life care in heart failure: A framework
for implementation/ UK/ 2010 [40].
Heart
Failure
inpatient/
outpatient
7 IPC: Holistic assessments, Patient’s goals, Suffering
reduction, ACP, Involvement of PC team, Last hours
of living care, Grief and bereavement care.
Low
the included pathways are described in different categories: title, country and year, type of disease, setting, Integrated Palliative Care (ICP) criteria and quality of
evidence. ACP= Advance Care Planning, EoL=End-of-Life, COPD= Chronic Obstructive Pulmonary Disorder.
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stated that the referral criteria should be for terminally
ill people without however defining the exact timing
[40]. One guideline encouraged considering integration
of PC from the moment of diagnosis or as soon as pos-
sible [27]. Finally, one guideline recommended that the
exact PC timing should depend on the frequency of hos-
pital admissions or exacerbations [38]. The referral cri-
teria distribution is presented in Fig. 2.
Only four (4/19) of the included guidelines/pathways
elaborate on aspects such as grief and bereavement care
(post mortem), seven (7/19) gave recommendations on
how to treat the patient in the last hours of life and with
continued goal adjustment mentioned in 8/19 of the ex-
amined documents.
Using the quality assessment for the evaluation of the
evidence (see Table 4), 6/17 guidelines/pathways scored
low for quality as they were based on consensus
methods only. One guideline was categorised as medium
quality; based on systematic review only or based on
other types of well referenced evidence. Finally, 12/19 of
guidelines/pathways were classified as high quality evi-
dence. According to our findings, the majority of the
guidelines/pathways were not devised in collaboration
with PC physicians. At this point it is important to high-
light that the assessment employed in this review does
not assess the quality of the implementation of the in-
cluded guidelines/pathways. Rather, it provides a means
of evaluating the principles upon which they have been
proposed.
Discussion
The majority of the included studies originated from the
UK (11 guidelines and one pathway). This is probably
due to the fact that PC originated from the UK [44]. The
Fig 1 Flow diagram of study selection procedure
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results revealed considerable discrepancies in the inte-
gration of PC guidelines, not only in the level of imple-
mentation, but in the level of what is conceptually
deemed important as well. However, despite such dispar-
ities, almost all guidelines/pathways emphasise that the
priority of integrated PC should be the reduction of suf-
fering, by effective symptom control. This convergence
of opinion is noteworthy for two reasons. First, it ac-
cords with what organizations such as the WHO [45],
the European Society of Cardiology [46], the European
Respiratory Society [47] and others identify as the pri-
mary objectives of PC. Second, it conforms to percep-
tions of both physicians and patients [48, 49].
The determination of the referral criteria in the appli-
cation of PC to patients with advanced CHF or COPD
has been a subject of debate [12, 50–54]. This is mainly
due to the fact that, as opposed to cancer, illness trajec-
tories of CHF and COPD are quite variable including se-
quences of deteriorations and (partial) relapses [55]. In
fact, even though prognosis of both advanced CHF and
COPD is poor [55, 56], prognostication is inexact. Also,
the predictive capacity of the various utilized tools is at
best moderate and is further reduced by the frequent oc-
currence of sudden deaths, frequent relapses, comorbid-
ity, and so on. Consequently, physicians are often
reluctant to discuss PC options and, interestingly, when
Table 7 Key point recommendations in relation to the IPC criteria provides the key recommendations of Integrated Palliative Care
of the included guidelines and pathways
IPC Criteria References of guidelines and
pathways
Key point recommendations
Discussion of illness
limitations and prognosis
[22–28, 30–35, 38, 39] “Open communication between patient and doctor.”
Holistic assessment [22, 23, 25, 26, 28–30, 33–35, 38–40] “Address physical, emotional, social and spiritual needs.”
Timing for holistic
assessments
[23, 27, 28, 31, 33–35, 38, 39] “Work closely with clinicians to agree on the indicators for
the exact timing of the holistic assessments.”
Timing for PC introduction [22–26, 28, 31–35, 38, 39] “Early integration of PC in the disease trajectory.”
Patient’s goals assessments [22–28, 30, 33, 34, 39, 40] “Disease specific management plans and care plans should be
based around patient’s personal goals.”
Continuous goal adjustment [22, 24, 28, 31, 33, 34, 38, 39] “Regular assessment of patients’ PC needs and continuous communication
and collaboration between care teams and organizations.”
Suffering reduction [22–29, 31–41] “Timely access to symptom control and administration of appropriate
medication”
Advance care planning (ACP) [22, 23, 28, 30, 31, 33–35, 38–40] “Early discussion of ACP, including patients’ end-of-life needs and preferences.”
Involvement of PC team [22, 23, 25, 26, 28–31, 33–36, 38, 40] “Specialist PC is provided by multi-professional PC teams, including physicians,
nurse specialists, psychologists, chaplains, social workers, pharmacists and other
appropriate allied health professionals.”
Recommendations on care
during the last hours of living
[22, 25, 28, 34, 35, 37, 40] “Care in the last days of life should be available 24 h a day, including rapid
access services, symptom control and assessment of end-of-life preferences.”
Grief and bereavement care
recommendations
[33–35, 40] “Provide family bereavement support and ensure there is access to
spiritual care and chaplaincy services.”
Fig 2 Absolute number of guidelines/pathways in relation to the referral criteria for PC
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they do so, the reaction of patients involves negative sur-
prise; this might also be attributed to the fact that public
understanding of these diseases is not linked to dying,
unlike for example cancer [57, 58].
In the present study, nearly half of the included guide-
lines/pathways did clarify referral criteria. However, even
among those that provide a recommendation, no appre-
ciable convergence of opinions was observed, as our
analysis demonstrated widely diverse referral criteria.
Moreover, the appropriateness of many of these referral
criteria is questionable because they heavily rely on
prognostication; in fact, even the three guidelines/path-
ways that opted for “last six months” did not based their
recommendation on the surprise question but rather on
prognostic models. Interestingly, at the same time,
guidelines recognise the need for communication be-
tween clinicians and patients concerning the limitations
of prognostication which appears to lead to a contradict-
ory view. A possible way to resolve this issue was dem-
onstrated by communicating to the patient the potential
risks involved in future admissions so paving the way for
an advance care planning discussion. Since only one
guideline explicitly promoted the early inclusion of PC
alongside standard treatment, it is evident that, despite
recommendations of medical associations [47], the per-
ception that PC should be primarily concerned with
“end-of-life” still prevails [59].
Concerning decision making and advanced care plan-
ning, patients with advanced CHF or COPD are quite
unlikely to get engaged in discussions concerning treat-
ment options/preferences and end-of-life issues because
i) patient-physician communication about end-of-life
care might be less likely to occur, ii) it is more compli-
cated to initiate this for patients with less certain prog-
nosis [60–62] and iii) as mentioned above, public
understanding of these diseases is not directly linked to
dying which can inflict negative reactions from patients
[57, 58]. The scarcity of patient-physician discussions
concerning treatment options/preferences and the fre-
quent total absence of discussions on end-of-life issues
result in less informed patients who are, nevertheless,
willing to both familiarize themselves with aspects of
their disease and express their preferences [63]; these
adverse effects are more apparent nowadays because
many patients search for relevant information on the
web and can thus challenge or question medical decision
making [64].
The majority of the included guidelines/pathways
identified the need for enhanced communication for
both treatment options/preferences and end-of-life is-
sues and explicitly advocate for it. Nonetheless, the ne-
cessary further steps to achieve this, such as advance
care planning and continuous goal adjustment are ab-
sent from a considerable amount of the included studies.
Consequently, since patient-physician communication,
advanced care planning and continuous goal adjustment
are interlinked, ignoring the latter two might result in
suboptimal PC. It is interesting to note that similar find-
ings were reported in a very recent systematic review of
integrated PC in guidelines and pathways in cancer,
which implies that poor communication is evident inde-
pendently of the disease trajectory [19].
The holistic approach to care including comprehensive
assessment of physical, psychological, spiritual and social
needs is backed by robust evidence [65–69]. However,
its practical implementation is quite challenging because
it is based on the well-orchestrated coordination of and
cooperation between different specialties while often re-
quiring the assumption of additional, novel duties from
the involved personnel. Current research has docu-
mented that these requirements are frequently unmet
due to implemented i) the reluctance of physicians to
advocate expansion of specialist PC services, ii) the
obscurity of the roles of doctors and nurses in different
specialties and iii) the limited funding and infrastructures
[69, 70]. As a consequence, the same studies hint that the
holistic approach is often poorly implemented in practice.
In view of these facts, we can infer that a stand-alone rec-
ommendation for the employment of the holistic ap-
proach is inadequate. Rather, such recommendations
should be supplemented with detailed instructions that
exemplify and quantify the roles of the involved personnel,
their interaction and timing of the assessments. The
prominence of the holistic approach is acknowledged by
the majority of the included guidelines/pathways [22, 25,
28]. Moreover, they provide specific recommendations for
controlling physical symptoms, relieving psychological is-
sues and addressing spiritual needs of the patients.
As regards the composition of the PC team, most of
the guidelines/pathways advocate a multidisciplinary ap-
proach that involves professionals from different disci-
plines who are additionally trained in PC [71]. The
advantages of the multidisciplinary approach over the
uni-disciplinary one have been documented and advo-
cated for multiple times in the literature both for CHF
and COPD [17, 45, 72–75]. It is also important to note
that combining a holistic approach with a multidiscip-
linary PC team has been posited to increase the bene-
fits of PC [76]. The advantages of this combination
have been recognized by most guidelines and path-
ways in this study.
Finally, our analysis revealed a lack of emphasis on
recommendations on the last hours of life and bereave-
ment care. It is striking that most of the guidelines/path-
ways identify PC as an end-of-life concept. Both aspects
have consistently been identified as significant
components of a complete and optimized integrated PC
[12, 77]. However, and despite being explicitly promoted
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[50, 78–80], they are frequently overlooked as is the case
with the present guidelines/pathways. Consequently, fu-
ture guidelines and pathways should increase their focus
on these aspects.
Study limitations
The search strategy employed herein is quite generic in
order to cover as many guidelines/pathways related to
CHF and COPD as possible which led to a large number
of titles being screened. The main reason for employing
this search strategy is because we conducted two studies,
one focusing on cancer patients (reported elsewhere)
and another focusing on CHF and COPD. It is conceiv-
able that a different search strategy would reveal a some-
what different list of results. Still, the employed search
strategy is deemed to be general enough to cover the
vast majority of the existing CHF and COPD studies.
This was supported through citation tracking and refer-
ence list checking.
The lack of a standardised and universally accepted
definition of integrated PC constitutes a limitation of
this study. As a consequence the search strategy uncov-
ered a rather heterogeneous body of working touching
on a variety of aspects of integrated PC. Still, the defin-
ition employed herein is deemed general enough to en-
capsulate the most relevant aspects of integrated PC.
A second limitation is linguistic and refers to the re-
striction to European guidelines/pathways published in
Dutch, English, French, German, Hungarian and Span-
ish. It is quite possible that several guidelines/pathways
exist in other European languages as well; our first elec-
tronic search returned potential candidates in Italian
and Swedish that were excluded for the reasons de-
scribed above. Further, additional information could
have been obtained if we had included studies from
other continents as well.
The third limitation of this study pertains to the tool
employed for the evaluation of the completeness of the
content of the guidelines/pathways. Following consensus
between the authors and the experts participating in the
InSup-C project, Emmanuel’s criteria were adopted on
the basis of their completeness. In fact, the range cov-
ered by Emmanuel’s criteria is large enough to ensure an
overlap with a potential alternative. Consequently, even
though the employment of a different evaluation tool
might have provided alternate results, modifications are
expected to be minor. It doesn’t however help us know
which guidelines work the best in practice.
Conclusions
We have systematically reviewed the literature for guide-
lines/pathways of integrating PC in patients with ad-
vanced CHF or COPD in Europe. Existing guidelines/
pathways thoroughly discuss the aspects like the
reduction of suffering, the holistic approach, the en-
hanced communication and the involvement of multi-
disciplinary PC team. However, other related aspects
such as referral criteria, advanced care planning, recom-
mendations on the last hours of life and bereavement
care are only partially touched or addressed. Moreover,
several suggested recommendations and solutions from
the guidelines are either insufficiently clear or even at
odds with existing directives and well-documented find-
ings. For example, several guidelines/pathways recom-
mended referral that rely on prognostication while at the
same time acknowledged the limitation for acquiring an
accurate one.
Overall, the results of this systematic study illustrate
that there is a growing awareness for the importance of
PC in patients with advanced CHF and COPD. At the
same time, however, they signal the need for the devel-
opment of standardized and conceptually unambiguous
strategies so that existing barriers are alleviated. In this
respect, given that prognostication for both CHF and
COPD is difficult, emphasis should be placed on the de-
termination of referral criteria that are independent of it
and thus straightforward to realise in practice. Moreover,
particular attention should be paid to the communica-
tion of end-of-life issues that consistently appears as a
bottleneck in PC for patients with advanced CHF and
CODP. Further, it is critical that the nearly total absence
of discussions concerning end-of-life issues is alleviated
so that both the efficacy of PC services and the number
of beneficiaries are enhanced. This is instrumental for
the improvement of existing PC practices that have been
consistently shown to be suboptimal.
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